Searched for
MAYNE PHARMA ACQUISITION
Bain dials Dr Reddy's Laboratories to team up for joint Cipla bidPrivate equity firm Bain Capital has approached Indian pharmaceutical company Dr Reddy's Laboratories (DRL) to explore a joint bid for the ...- Dr Reddy's Q1 Results: Net profit rises 18% YoY to Rs 1403 croreIndian drug company Dr Reddy's plans to use its net cash surplus of INR 5,000 crore ($670m) to fund acquisitions and innovations aiming at ...
- Dr Reddy's Q1 Results: PAT up 18% YoY at Rs 1,405 crore, tops estimateThe EBITDA or earnings before interest, taxes, depreciation, and amortisation, for the quarter increased 20% on year to Rs 2,137 crore. How...
- Q1 earnings: 26 companies that may report over 100% jump in profitDomestic brokerage Motilal expects Nifty earnings to grow 25% YoY in Q1. Oil and gas sector may report a 3x surge in profit YoY underpinned...
- Dr Reddy's tumbles 7% post Q4 results! Here's what brokerages recommendDr Reddy's Laboratories reported an 890% YoY surge in March quarter profit at Rs 960.1 crore but shares tumbled nearly 7% to Rs 4,545 in Th...
- Stocks in news: Adani Wilmar, Titan, Tata Motors, Mahindra FinanceTata Motors global wholesales in the fourth quarter, including Jaguar Land Rover, were at 3,61,361 units, higher by 8%, as compared to the ...
- Dr Reddy's to acquire Mayne Pharma US generic portfolio for $105 millionUnder the terms of the agreement, Dr. Reddy’s will acquire the portfolio for an upfront payment of $90 million in cash, contingent payments...
- Intas buys Teva's UK & Ireland assets for $764 million to break into global top 20 generic players clubWith the acquisition of Teva’s products, sold through erstwhile Actavis’ operations, Intas is set to emerge as a top player in the UK gener...
- Aurobindo, Intas in race for $1 billion buyout of Teva UK, submit binding offersIf successful, this would be Aurobindo's largest ever acquisition, surpassing its $132.5 mn purchase of US vitamin maker Natrol Inc in 2014.
- DRL, Cipla, Aurobindo among others to buy products from TevaThe remedy requires Teva to divest the drug portfolio to 11 firms and marks the largest drug divestiture order in an FTC pharmaceutical mer...
- Torrent, Intas join fray for teva products in EuropeThe deal, said to be valued up to $1.5 billion, has seen the Hyderabadbased Aurobindo Pharma emerge as one of the front runners in the init...
- US-based Hospira to buy Orchid Chemicals' injectables biz for $400 mnOrchid Chemicals & Pharmaceuticals to sell its injectables business to the US-based Hospira for around $400 million.
- Hospira-Mayne deal likely to alter pharma equations hereOne of the biggest trans-continent deals in the generic pharma sector is likely open the floodgates of opportunities for the Indian pharma ...
Load More
